This event is designed for patents, health professionals and stakeholders from both academia and industry who are involved in or specialize in GBA1 research. Topics will cover all aspects of GBA1, ranging from basic science to clinical trials. The meeting will provide a unique platform to collaboratively advance the understanding and treatment of GBA1-associated neuro-degenerative diseases
Register today
We are delighted to announce the upcoming GBA1 Meeting 2026 — a satellite event of the World Parkinson Congress — taking place on May 22–23, 2026, in Phoenix, Arizona. Building on the momentum of previous years, this meeting will once again bring together scientists, clinicians, patients, and industry partners to advance research and treatment for GBA1-associated neurodegenerative diseases.
We look forward to welcoming you in Phoenix for another inspiring and collaborative GBA1 Meeting.
Read more
Associate Professor, The Neuro (Montreal Neurological Institute- Hospital) & McGill University

NAP-Med Laboratory Manager/GP2 Project Manager, The Neuro (Montreal Neurological Institute-Hospital) & McGill University

GBA1 Program Manager, GBA1 Canada Initiative, The Neuro (Montreal Neurological Institute- Hospital) & McGill University

Scientific Academic Associate, GBA1 Canada Initiative, The Neuro (Montreal Neurological Institute-Hospital) & McGill University

Officer, Research Alliances at The Michael J. Fox Foundation

Associate Professor, The Neuro (Montreal Neurological Institute- Hospital) & McGill University

Vice President, Discovery & Translational Research, The Michael J. Fox Foundation for Parkinson’s Research

Chief of the Movement Disorders Division at Tel Aviv Sourasky Medical Center in Tel Aviv & Associate professor, part-time, Columbia University

Nanyang Assistant Professor, Lee Kong Chian School of Medicine, Nanyang Technological University Singapore

Associate Professor of Neurology Northwestern University Feinberg School of Medicine, Department of Neurology